News

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...
After the emotional shock of a breast cancer recurrence, Teah decided to seek care – and proton therapy – at Fred Hutch ...
Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...
During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that ...
A new AI application that is part of an 'ambient listening' pilot program is helping physicians at Fred Hutch Cancer Center ...
Fred Hutch researchers have created a gene-expression map of glial cells of the tiny worm, C. elegans, adding the missing ...
Fred Hutch Cancer Center aims to enroll 200,000 patients over the next 10 years in a new research program called TakePART-NW (Patients and Research Together-Northwest) to improve screening, prevention ...
Thanks to generous support and partnership from Alexandria Real Estate Equities, Inc., Fred Hutch has a new, state-of-the-art learning laboratory where high school and college students who participate ...
Hepatic artery infusion (HAI) therapy offers a new approach for people whose colorectal cancer has spread to the liver. It allows physicians to deliver chemotherapy directly to the liver at doses up ...
Fred Hutch biostatistician Dr. Peter Gilbert received the 2025 Marvin Zelen Leadership Award in Statistical Science recognizing his contributions to HIV vaccine trial design and analysis.
Dr. Songli Zhu at work in the Tissue Culture room in the Gujral Lab at Fred Hutch. Zhu, Gujral and other researchers from Fred Hutch and the University of Washington just published a paper in Gut that ...
Fred Hutch and MSK researchers showed that tumors driven by hiccups in RNA processing can't hid from the immune system. In work published in Cell, the team showed they could isolate T cells that ...